SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00592-022-02015-6.pdf
Reference34 articles.
1. Brown E, Rajeev SP, Cuthbertson DJ, Wilding JPH (2019) A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitors. Diabetes Obes Metab 21(Suppl):2. https://doi.org/10.1111/dom.13650
2. Zelniker TA, Braunwald E (2018) Cardiac and renal effects of sodium-glucose co-transporter 2 inhibitors in diabetes: JACC state-of-the-art review. J AM Coll Cardiol 72:1845–1855. https://doi.org/10.1016/j.jacc.2018.06.040
3. Furtado RHM, Bonaca MP, Raz I et al (2019) Dapagliflozin and in cardiovascular outcomes patients with type 2 diabetes mellitus and previous myocardial infarction. Circulation 139:2516–2527. https://doi.org/10.1161/CIRCULATIONAHA.119.039996
4. Mahaffey KW, Neal B, Perkovic V et al (2018) Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin cardiovascular assessment study). Circulation 137:323–334. https://doi.org/10.1161/CIRCULATIONAHA.117.032038
5. McGuire DK, Zinman B, Inzucchi SE et al (2020) Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial Lancet. Diabetes Endocrinol 8:949–959. https://doi.org/10.1016/S2213-8587(20)30344-2
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dapagliflozin Use in Children with Advanced Heart Failure Undergoing Heart Transplantation: A Matched Case-Control Study;Pediatric Cardiology;2024-07-22
2. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report;Diabetes Care;2024-06-22
3. Hyperglycaemic crises in adults with diabetes: a consensus report;Diabetologia;2024-06-22
4. Efficacy and safety of once daily oral administration of sodium‐glucose cotransporter‐2 inhibitor velagliflozin compared with twice daily insulin injection in diabetic cats;Journal of Veterinary Internal Medicine;2024-06-17
5. Safety assessment of dapagliflozin: Real-world adverse event analysis based on the FAERS database from 2012 to 2023;Heliyon;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3